1 / 13

Prescription Narcotics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 201

Prescription narcotics are drugs that relieve body pain and binds itself to receptors to lessen and block the pain signals. Growing inefficiency of existing medicines coupled with rising cases of chronic pain is driving the growth of the market. The rising demand for opioids to treat chronic pain conditions is stimulating market growth. Opioids are effective in severe treat management. Opioids like fentanyl and tramadol are used in vast numbers to treat severe and moderate level of pain. According to figures of CDC, approximately 11% of the adult population in the US is experiencing some form of chronic pain. In addition, changing regulatory conditions to encourage the utilization of narcotics has led to the potential growth of the market.<br> The market is segmented by indication, sales channel, and region. Based on indication, analgesics segment is expected to drive market growth. Analgesics are strong and provide relief without the person losing consciousness. Analgesics can be used for diagnostics of migraines, gallbladder disease, headaches, osteoarthritis, menstruation, fibromyalgia, and rheumatoid arthritis. Such advantages offered by analgesics is set to bolster the demand of the market.<br>Based on the sales channel, retail pharmacies are expected to dictate the growth of the market. The rapid expansion of the healthcare industry has resulted in an escalation of the retail pharmacy. The rise in chronic diseases and increase involvement of government to provide effective medicines is driving the demand for retail pharmacies.<br> According to the United States National Institute of Healthcare (NIH) , 2 million among the US population and 15 million across the globe have been affected by opioid dependency. In 2016, more than 35,000 deaths were caused by misuse of opioids. According to the National Institute on Drug Abuse, nearly 2.3 million people in the U.S. were addicted to prescription opioids. 47,000 people died of opioid overdose. Such incidents have hindered the growth of the market. This has led US government to announce addiction of opioid as public health emergency which has restricted the growth of the market.<br> In terms of region, North America is the global leader of the market. The increasing number of manufacturers coupled with the rising geriatric population is driving the growth of the market in the region. Moreover, government laws and regulations are fueling market growth in the region. Stringent scrutiny from the FDA to inspect the prescribed drugs is boosting market expansion further. The Risk Evaluation and Mitigation Strategy (REMS) program focus on educating and creating awareness among doctors regarding pain management and patient awareness for safe usage of drugs are propelling the market as well.<br> Asia-Pacific region is expected to witness notable growth owing to the rise in disposable income and increasing adoption of opioids in clinical practices. Furthermore, higher incidents of chronic pain are stimulating market growth in the region. Additionally, government regulations are boosting the market presence in the region. The Pharmaceuticals and Medical Devices Agency (PMDA) of Japenese government monitors prescription drug promotion and advertising. Such regulations have bolstered the market in the region.<br>Additional Insights:<br>u2022 In order to combat the addiction of opioids, Medicare in 2019 imposed new guidelines for prescribing opioids. The guidelines state that Medicare patients cannot be prescribe with a daily dosage of opoid<br>u2022 The FDA's Office of Prescription Drug Promotion (OPDP) reviews prescribed drug advertising to make sure the information displayed isn't misleading or false. Such impositions have reduced the opioid addiction and further strengthened the market in the North America region<br> <br><br>Request a Sample Report @https://www.futurewiseresearch.com/request-sample.aspx?id=214&page=requestsample<br>Prescription Narcotics Market Segmentation:<br>By Indication<br>u2022 Cancer Pain<br>u2022 Trauma<br>u2022 Analgesics<br>u2022 Others<br> <br>By Sales Channel<br>u2022 Retail Pharmacies<br>u2022 Institutional Distribution<br> <br>By Region:<br>u2022 North America<br>u2022 Latin America<br>u2022 Europe<br>u2022 Asia Pacific<br>u2022 Rest of the World<br> <br> Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=214&page=askfordiscount<br>Competitive Landscape:<br>u2022 Tier 1 players- established companies in the market with a major market share<br>u2022 Tier 2 players<br>u2022 Emerging players which are growing rapidly<br>u2022 New Entrants <br> <br>FutureWise Key Takeaways<br>u2022 Growth prospects<br>u2022 SWOT analysis<br>u2022 Key trends<br>u2022 Key data-points affecting market growth<br> <br>Objectives of the Study:<br>u2022 To provide with an exhaustive analysis on the global prescription narcotics market by indications, sales channel, and by region<br>u2022 To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)<br>u2022 To evaluate and forecast micro-markets and the overall market<br>u2022 To predict the market size, in key regions (along with countries)u2014North America, Europe, Asia Pacific, Latin America, and rest of the world<br>u2022 To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions<br>u2022 Profiling of companies to evaluate their market shares, strategies, financials and core competencies <br><br>Table of Contents<br>Introduction<br>Scope and Objective<br>Assumptions and Acronyms<br>Forecast Factors<br>Research Methodology<br>Executive Summary<br>Industry Cluster Analysis<br>Competition Matrix<br>Strategies Recommendations<br>Market Definition<br>Report Scope (Inclusions & Exclusions)<br>Market Segmentation<br>Global Prescription Narcotics Market Overview<br>Global Prescription Narcotics Market Revenue (USD Mn)<br>Key Inclusions<br>Porteru2019s Five Force analysis<br>Market Dynamics<br>Industry Trends<br>Regulatory Guidelines<br>Opportunities in Prescription Narcotics<br>Competition Dynamics<br>Company Share Analysis (2019)<br>Top 10 Product Pricing by Region<br>Global Prescription Narcotics Market Revenue (USD Mn), 2019-2026 by Indication<br>Key Market Findings<br>Long Term ROI Segments<br>Revenue Opportunity Influencing Factors<br>Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019-2026<br>Cancer Pain<br>Trauma<br>Analgesics<br>Others<br>Global Prescription Narcotics Market Revenue (USD Mn), 2019-2026 by Sales Channel<br>Key Market Findings<br>Long Term ROI Segments<br>Revenue Opportunity Influencing Factors<br>Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026<br>Retail Pharmacies<br>Institutional Distribution<br>Global Prescription Narcotics Market Revenue (USD Mn), 2019-2026 by Region<br>Key Market Findings<br>Long Term ROI Segments<br>Revenue Opportunity Influencing Factors<br>Market Revenue (USD Mn) Assessment and Forecast by Region,2026<br>North America<br>Latin America<br>Europe<br>Asia Pacific<br>Rest of world<br>North America Prescription Narcotics Market Revenue (US$ Mn), 2019-2026<br>Key Market Findings<br>Long Term ROI Segments <br>Revenue Opportunity Influencing Factors<br>Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026<br>US<br>Canada<br>Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019-2026<br>Cancer Pain<br>Trauma<br>Analgesics<br>Others<br>Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026<br>Retail Pharmacies<br>Institutional Distribution<br>Latin America Prescription Narcotics Market Revenue (US$ Mn), 2019-2026<br>Key Market Findings<br>Long Term ROI Segments <br>Revenue Opportunity Influencing Factors<br>Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026<br>Brazil<br>Mexico<br>Argentina<br>Rest of Latin America<br>Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019-2026<br>Cancer Pain<br>Trauma<br>Analgesics<br>Others<br>Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026<br>Retail Pharmacies<br> Institutional Distribution<br>Europe America Prescription Narcotics Market Revenue (US$ Mn), 2019-2026<br>Key Market Findings<br>Long Term ROI Segments <br>Revenue Opportunity Influencing Factors<br>Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026<br>Germany<br>France<br>Spain<br>UK<br>Russia<br>Poland<br>Rest of Europe<br>Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019-2026<br>Cancer Pain<br>Trauma<br>Analgesics<br>Others<br>Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026<br>Retail Pharmacies<br>Institutional Distribution<br>Asia Pacific America Prescription Narcotics Market Revenue (US$ Mn), 2019-2026<br>Key Market Findings<br>Long Term ROI Segments <br>Revenue Opportunity Influencing Factors<br>Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026<br>Emerging Asia<br>China<br>India<br>ASEAN-5<br>Rest of Emerging Asia<br>Japan<br>Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019-2026<br>Cancer Pain<br>Trauma<br>Analgesics<br>Others<br>Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026<br>Retail Pharmacies<br>Institutional Distribution<br>Rest of World America Prescription Narcotics Market Revenue (US$ Mn), 2019-2026<br>Key Market Findings<br>Long Term ROI Segments <br>Revenue Opportunity Influencing Factors<br>Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026<br>Middle East<br>South Africa<br>North Africa<br>Rest of World<br>Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019-2026<br>Cancer Pain<br>Trauma<br>Analgesics<br>Others<br>Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026<br>Retail Pharmacies<br> Institutional Distribution<br>Company Profiles<br>Competition Landscape<br>Global Company Share (USD Mn) Overview, 2019<br>Company Profiles<br>Pfizer Inc<br>Corporate Overview<br>Financial Performance<br>Peer Comparison & 3C marketing equation<br>Company Strategy & Channel Management<br>Novartis AG<br>Corporate Overview<br>Financial Performance<br>Peer Comparison & 3C marketing equation<br>Company Strategy & Channel Management<br>J&J<br>Corporate Overview<br>Financial Performance<br>Peer Comparison & 3C marketing equation<br>Company Strategy & Channel Management<br>Merck Co. & Inc<br>Corporate Overview<br>Financial Performance<br>Peer Comparison & 3C marketing equation<br>Company Strategy & Channel Management<br>Roche Holding<br>Corporate Overview<br>Financial Performance<br>Peer Comparison & 3C marketing equation<br>Company Strategy & Channel Management<br>Bayer AG<br>Corporate Overview<br>Financial Performance<br>Peer Comparison & 3C marketing equation<br>Company Strategy & Channel Management<br>AstraZeneca<br>Corporate Overview<br>Financial Performance<br>Peer Comparison & 3C marketing equation<br>Company Strategy & Channel Management<br>Sanofi Plc<br>Corporate Overview<br>Financial Performance<br>Peer Comparison & 3C marketing equation<br>Company Strategy & Channel Management<br>Research Sources & Primary Verbatim<br>Inquire further details about this report at: sales@futurewiseresearch.com <br><br>About FutureWise Research:<br>We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry u2013 a position secured for far more than the near future. <br><br>Contact Us:<br>Company Name: FutureWise Research <br>Contact Person: Vinay Thaploo<br>Email: sales@futurewiseresearch.com <br>Phone: 44 141 628 9353 / 1 970 279 4295 <br>City: Leeds<br>Country: United Kingdom<br>Website: www.futurewiseresearch.com<br>

diwanjia97
Télécharger la présentation

Prescription Narcotics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 201

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Prescription Narcotics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026 Prescription narcotics are drugs that relieve body pain and binds itself to receptors to lessen and block the pain signals. Growing inefficiency of existing medicines coupled with rising cases of chronic pain is driving the growth of the market. The rising demand for opioids to treat chronic pain conditions is stimulating market growth. Opioids are effective in severe treat management. Opioids like fentanyl and tramadol are used in vast numbers to treat severe and moderate level of pain. According to figures of CDC, approximately 11% of the adult population in the US is experiencing some form of chronic pain. In addition, changing regulatory conditions to encourage the utilization of narcotics has led to the potential growth of the market. The market is segmented by indication, sales channel, and region. Based on indication, analgesics segment is expected to drive market growth. Analgesics are strong and provide relief without the person losing consciousness. Analgesics can be used for diagnostics of migraines, gallbladder disease, headaches, osteoarthritis, menstruation, fibromyalgia, and rheumatoid arthritis. Such advantages offered by analgesics is set to bolster the demand of the market. Based on the sales channel, retail pharmacies are expected to dictate the growth of the market. The rapid expansion of the healthcare industry has resulted in an escalation of the retail pharmacy. The rise in chronic diseases and increase involvement of government to provide effective medicines is driving the demand for retail pharmacies. According to the United States National Institute of Healthcare (NIH) , 2 million among the US population and 15 million across the globe have been affected by opioid dependency. In 2016, more than 35,000 deaths were caused by misuse of opioids. According to the National Institute on Drug Abuse, nearly 2.3 million people in the U.S. were addicted to prescription opioids. 47,000 people died of opioid overdose. Such incidents have hindered the growth of the market. This has led US government to announce addiction of opioid as public health emergency which has restricted the growth of the market. In terms of region, North America is the global leader of the market. The increasing number of manufacturers coupled with the rising geriatric population is driving the growth of the market in the region. Moreover, government laws and regulations are fueling market growth in the region. Stringent scrutiny from the FDA to inspect the prescribed drugs is boosting market expansion further. The Risk Evaluation and Mitigation Strategy (REMS) program focus on educating and creating awareness among doctors regarding pain management and patient awareness for safe usage of drugs are propelling the market as well.

  2. Asia-Pacific region is expected to witness notable growth owing to the rise in disposable income and increasing adoption of opioids in clinical practices. Furthermore, higher incidents of chronic pain are stimulating market growth in the region. Additionally, government regulations are boosting the market presence in the region. The Pharmaceuticals and Medical Devices Agency (PMDA) of Japenese government monitors prescription drug promotion and advertising. Such regulations have bolstered the market in the region. Additional Insights: · In order to combat the addiction of opioids, Medicare in 2019 imposed new guidelines for prescribing opioids. The guidelines state that Medicare patients cannot be prescribe with a daily dosage of opoid · The FDA's Office of Prescription Drug Promotion (OPDP) reviews prescribed drug advertising to make sure the information displayed isn't misleading or false. Such impositions have reduced the opioid addiction and further strengthened the market in the North America region Request a Sample Report@https://www.futurewiseresearch.com/request- sample.aspx?id=214&page=requestsample Prescription Narcotics Market Segmentation: By Indication · Cancer Pain · Trauma · Analgesics · Others By Sales Channel · Retail Pharmacies · Institutional Distribution

  3. By Region: · North America · Latin America · Europe · Asia Pacific · Rest of the World Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request- sample.aspx?id=214&page=askfordiscount Competitive Landscape: · Tier 1 players- established companies in the market with a major market share · Tier 2 players · Emerging players which are growing rapidly · New Entrants FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study:

  4. • To provide with an exhaustive analysis on the global prescription narcotics market by indications, sales channel, and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents Introduction Scope and Objective Assumptions and Acronyms Forecast Factors Research Methodology Executive Summary Industry Cluster Analysis Competition Matrix Strategies Recommendations Market Definition Report Scope (Inclusions & Exclusions) Market Segmentation Global Prescription Narcotics Market Overview

  5. Global Prescription Narcotics Market Revenue (USD Mn) Key Inclusions Porter’s Five Force analysis Market Dynamics Industry Trends Regulatory Guidelines Opportunities in Prescription Narcotics Competition Dynamics Company Share Analysis (2019) Top 10 Product Pricing by Region Global Prescription Narcotics Market Revenue (USD Mn), 2019-2026 by Indication Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019- 2026 Cancer Pain Trauma Analgesics Others Global Prescription Narcotics Market Revenue (USD Mn), 2019-2026 by Sales Channel Key Market Findings Long Term ROI Segments

  6. Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026 Retail Pharmacies Institutional Distribution Global Prescription Narcotics Market Revenue (USD Mn), 2019-2026 by Region Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Region,2026 North America Latin America Europe Asia Pacific Rest of world North America Prescription Narcotics Market Revenue (US$ Mn), 2019-2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2019- 2026 US Canada Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019- 2026

  7. Cancer Pain Trauma Analgesics Others Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026 Retail Pharmacies Institutional Distribution Latin America Prescription Narcotics Market Revenue (US$ Mn), 2019-2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2019- 2026 Brazil Mexico Argentina Rest of Latin America Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019- 2026 Cancer Pain Trauma Analgesics Others

  8. Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026 Retail Pharmacies Institutional Distribution Europe America Prescription Narcotics Market Revenue (US$ Mn), 2019-2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2019- 2026 Germany France Spain UK Russia Poland Rest of Europe Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019- 2026 Cancer Pain Trauma Analgesics Others Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026

  9. Retail Pharmacies Institutional Distribution Asia Pacific America Prescription Narcotics Market Revenue (US$ Mn), 2019- 2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2019- 2026 Emerging Asia China India ASEAN-5 Rest of Emerging Asia Japan Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019- 2026 Cancer Pain Trauma Analgesics Others Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026 Retail Pharmacies Institutional Distribution

  10. Rest of World America Prescription Narcotics Market Revenue (US$ Mn), 2019- 2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2019- 2026 Middle East South Africa North Africa Rest of World Market Revenue (USD Mn) Assessment and Forecast by Indication, 2019- 2026 Cancer Pain Trauma Analgesics Others Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2019-2026 Retail Pharmacies Institutional Distribution Company Profiles Competition Landscape Global Company Share (USD Mn) Overview, 2019 Company Profiles

  11. Pfizer Inc Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Novartis AG Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management J&J Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Merck Co. & Inc Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Roche Holding Corporate Overview Financial Performance

  12. Peer Comparison & 3C marketing equation Company Strategy & Channel Management Bayer AG Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management AstraZeneca Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Sanofi Plc Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Research Sources & Primary Verbatim Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us:

  13. Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com

More Related